Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Dixon, C. Edward | Kraus, Marilyn F. | Kline, Anthony E. | Ma, Xiecheng | Yan, Hong Q. | Griffith, Raymond G. | Wolfson, Brian M. | Marion, Donald W.
Affiliations: Department of Neurosurgery, University of Pittsburgh Medical Center, PA, USA | Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh. Pittsburgh, PA, USA
Note: [] Correspondence: Brain Trauma Research Center, Department of Neurosurgery, University of Pittsburgh, 3434 Fifth Ave., Suite 201, Pittsburgh, PA 15260, USA. Phone: +1-412-383-2188; Fax: +1-412-624-0943; E-mail: [email protected]
Abstract: Amantadine, a dopamine agonist, is reported to have beneficial effects on the neurobehavioral sequelae of clinical brain injury. However, there are currently no published laboratory reports on its use in the assessment of functional or histopathological outcome following experimental traumatic brain injury (TBI). To this end, we examined the effects of daily amantadine treatment on functional recovery (motor and Morris water maze performance) and hippocampal neuronal survival following controlled cortical impact (CCI) injury (4 meters/sec, 2.7 mm tissue deformation). Male Sprague-Dawley rats were pretrained on motor performance tasks (beam balance and beam walking) one day prior to injury and tested on post-operative days 15. Additionally, all subjects were trained on the Morris water maze on post-operative days 1418. Beginning one day after CCI injury or sham surgery, animals were injected once daily for 18 days with either amantadine (10 mg/kg, i.p.) or saline. The amantadine treatment regimen was ineffective in promoting motor recovery and increasing survival of hippocampal neurons in both the CA1 and CA3 regions following TBI, but did show improved swim latencies during the five days of water maze testing (Day 14 vs. Day 18, p < 0.01) when compared to saline controls. Mean (± SE) swim latencies on Day 18 were 15.12 ± 2.8, 13.25 ± 4.18, 70.83 ± 11.1, and 38.5 ± 3.55 sec for the sham/saline, sham/amantadine, injured/saline, and injured/amantadine treatment groups, respectively. Thus, while the daily administration of amantadine exhibited a neutral effect on motor behavior, it produced a modest attenuation of water maze performance deficits. This latter finding is consistent with published clinical data suggesting a beneficial effect on functional outcome with amantadine therapy.
Keywords: brain injury, amantadine, dopamine , rat
Journal: Restorative Neurology and Neuroscience, vol. 14, no. 4, pp. 285-294, 1999
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]